Raeann Meyer, PA
Physician Assistant · Fremont, NENPI 1679658058
Payments from drug & device makers
Across 151 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$823
- Amgen$290
- Novo Nordisk$223
- Otsuka America Pharmaceutical, Inc.$186
- Lilly USA, LLC$105
- Boehringer Ingelheim$104
- plus $733 from 22 others
What the payments were for
- Food & beverage$2,41898%
- Other$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $823 |
| Amgen | 19 | $290 |
| Novo Nordisk | 15 | $223 |
| Otsuka America Pharmaceutical, Inc. | 11 | $186 |
| Lilly USA, LLC | 7 | $105 |
| Boehringer Ingelheim | 7 | $104 |
| AstraZeneca | 6 | $94 |
| Johnson & Johnson | 6 | $88 |
| Bayer | 5 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Welch Allyn | 1 | $45 |
| Pfizer | 3 | $44 |
| Boston Scientific | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Novartis | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Vertex | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Abbott | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Gilead | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Organon | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$2,464 in reported general payments places this provider in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $58,178 |
| XareltoRivaroxaban | 40 | $24,893 |
| TrulicityDulaglutide | 19 | $18,468 |
| JardianceEmpagliflozin | 27 | $15,315 |
| Nurtec OdtRimegepant Sulfate | 13 | $15,117 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $6,796 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $6,065 |
| Atorvastatin Calcium | 400 | $3,540 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $2,676 |
| Omeprazole | 199 | $2,462 |
| Gabapentin | 112 | $1,858 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $1,828 |
| Pravastatin Sodium | 144 | $1,652 |
| Levothyroxine Sodium | 175 | $1,391 |
| Amlodipine Besylate | 158 | $1,368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt | $44 | $73,29572 claims |
| Johnson & JohnsonXarelto | $88 | $24,89340 claims |
| Lilly USA, LLCTrulicity | $105 | $18,46819 claims |
| Boehringer IngelheimJardiance | $104 | $15,31527 claims |
| AstraZenecaSymbicort | $94 | $6,79624 claims |
| AbbVieSynthroid | $823 | $37514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Fremont
- Ami JonesFremont$8K
- Rita FowlerFremont$7K
- Ronald KmiecikFremont$6K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.